The company maintains that it is not moving to oust Pfizer’s vaccine from the market nor is it seeking to prevent future sales of its vaccine.
The increase was by 30.1 per cent to 9.57 billion euros (9.74 billion dollars) compared to the first half of 2021.
The focus of Mr Steinmeier’s visit which will lasts until Wednesday, will be the establishment of facilities to produce COVID-19 vaccines in Africa.
This comes days after Rwanda signed another contract with BioNTech to establish manufacturing capacity for vaccines in the country.
“Our findings highlight that vaccination of pregnant women may provide maternal and neonatal protection from SARS-CoV-2.”
“The majority of sellers came from France, Germany, the UK, and the USA, and the prices per dose ranged from $250 to $1,200.”
European countries are moving fast to innoculate its citizens after the first batch of vaccines were delivered.
Moderna’s is the second vaccine to get FDA’s nod, a week after Pfizer and its German partner, BioNTech, got approval.
The prime minister wishes to demonstrate the effectiveness of the vaccine.
Milestone comes as Pfizer and BioNtech are announcing a breathrough in development of a vaccine with 95 percent efficacy.
